- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 21, 2025 | 1.35B sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $725.6M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $748.54M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.09B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.17B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.55B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.55B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.66B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.78B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.04B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.2B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 1.38B sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $27.01M |
| Capex | Q1 2025 · Mar 31, 2024 | $132.7M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $569.23M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.36B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.06B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.26 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.26 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $204.63M |
| Net Income | Q1 2025 · Mar 31, 2024 | $359.29M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $441.29M |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.7B |